Koller W, Curtin J, Fields J
Neuropharmacology. 1984 Oct;23(10):1191-4. doi: 10.1016/0028-3908(84)90238-7.
Molindone was compared with haloperidol in animal models of tardive dyskinesia. Treatment with molindone for 14 days at 3, 6, 20 and 40 mg/kg, enhanced the stereotyped behavioral response induced by apomorphine and increased the numbered of D-2 dopamine receptors in the striatum (Bmax) labelled by high affinity (Kd = 40 pmol) binding or [3H] spiroperidol in the guinea-pig. Molindone at 1 mg/kg, caused no behavioral supersensitivity or change in the binding of dopamine receptors. Chronic administration of haloperidol (0.1, 0.5 and 5.0 mg/kg) also increased both the behavioral response to apomorphine and the number of dopamine receptors. Haloperidol, at 0.02 and 0.004 mg/kg, had no effect. Molindone potentiated dopaminergic activity in animal models in a similar way to other neuroleptics, suggesting that its use may also result in tardive dyskinesia.
在迟发性运动障碍的动物模型中,对吗茚酮与氟哌啶醇进行了比较。以3、6、20和40mg/kg的剂量对豚鼠给予吗茚酮治疗14天,增强了阿扑吗啡诱导的刻板行为反应,并增加了纹状体中由高亲和力(Kd = 40 pmol)结合或[3H]螺哌啶醇标记的D-2多巴胺受体数量(Bmax)。1mg/kg的吗茚酮未引起行为超敏反应或多巴胺受体结合的变化。长期给予氟哌啶醇(0.1、0.5和5.0mg/kg)也增加了对阿扑吗啡的行为反应以及多巴胺受体的数量。0.02和0.004mg/kg的氟哌啶醇没有效果。吗茚酮在动物模型中以与其他抗精神病药物类似的方式增强了多巴胺能活性,这表明其使用也可能导致迟发性运动障碍。